perceive to changing their PSA screening practices. We will then discuss reasons why narrative communication techniques hold promise for achieving the substantial shifts in provider motivation and self-efficacy needed to address the problem of prostate cancer overdiagnosis. We will end by describing a specific web-based intervention employing narrative communication techniques we are developing to motivate and empower physicians to discontinue PSA screening. Title Dr. City Minneapolis Full Name Melissa R. Partin Country USA Affiliation Center for Chronic Disease Outcomes Phone 612-467-3841 Research Institutional Minneapolis VA Medical Center Fax 612-467-5699 Address 1 Veterans Drive Minneapolis MN 55417 55417 Melissa.partin@va.gov Postal code E-mail Abstract #88 - ON OVERDIAGNOSIS IN BREAST CANCER WOMEN’S VIEWS SCREENING: A QUALITATIVE STUDY Hersch, J; Barratt, A; Jansen, J; Irwig, L; Houssami, N; Howard, K; Dhillon, H; McCaffery, K University of Sydney; Sydney, NSW, Australia Background: While mammography screening can reduce breast cancer mortality, it also carries a risk of overdiagnosis an important harm largely unknown to the public at present. – Aims: We responses to information about the nature and extent of elicited women’s overdiagnosis in mammography screening, and explored how awareness of overdiagnosis might influence screening attitudes and intentions. Methods: We conducted a qualitative study using focus groups that included a presentation explaining overdiagnosis, incorporating different published estimates of its rate (1–10%, 30%, 50%) and information on the mortality benefit of screening, with guided group discussions. Participants included 50 women aged 40–79 years with no personal history of breast cancer, varying in educational background and previous participation in screening.
perceive to changing their PSA screening practices. We will then discuss reasons why narrative communication techniques hold promise for achieving the substantial shifts in provider motivation and self-efficacy needed to address the problem of prostate cancer overdiagnosis. We will end by describing a specific web-based intervention employing narrative communication techniques we are developing to motivate and empower physicians to discontinue PSA screening. Title Dr. City Minneapolis Full Name Melissa R. Partin Country USA Affiliation Center for Chronic Disease Outcomes Research Phone 612-467-3841 Institutional Address Minneapolis VA Medical Center 1 Veterans Drive Minneapolis MN 55417 Fax 612-467-5699 Postal code 55417 E-mail Melissa.partin@va.gov Abstract #88 - WOMEN’S VIEWS ON OVERDIAGNOSIS IN BREAST CANCER SCREENING: A QUALITATIVE STUDY Hersch, J; Barratt, A; Jansen, J; Irwig, L; Houssami, N; Howard, K; Dhillon, H; McCaffery, K University of Sydney; Sydney, NSW, Australia Background: While mammography screening can reduce breast cancer mortality, it also carries a risk of overdiagnosis – an important harm largely unknown to the public at present. Aims: We elicited women’s responses to information about the nature and extent of overdiagnosis in mammography screening, and explored how awareness of overdiagnosis might influence screening attitudes and intentions. Methods: We conducted a qualitative study using focus groups that included a presentation explaining overdiagnosis, incorporating different published estimates of its rate (1–10%, 30%, 50%) and information on the mortality benefit of screening, with guided group discussions. Participants included 50 women aged 40–79 years with no personal history of breast cancer, varying in educational background and previous participation in screening.
POD-Abstracts.docx